Browsing by Subject "Health Care Costs"
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
Item Economics in medicine: a physician's perspective(2017-11-10) Chen, CatherineItem Getting to 100% insurance coverage: lessons from Canada's single-payer health insurance system(2021-10-29) Cram, PeterItem Health care systems around the world, socialized, private.....What can we learn?(2010-07-30) Gruntmanis, UgisItem Home based primary care: an economic(2018-07-27) Jamshed, NamirahItem Physicians, healthcare costs, and society: who's responsible for what?(2015-10-13) Tilburt, Jon C.Physicians play a key role in the utilization of healthcare financial resources. The unsustainable rise in the cost of healthcare in the US implies physicians should be part of addressing rising costs to make them more sustainable. But how can they do so with integrity? Ancient vows of medicine require fidelity to individual best interests. Modern norms of social contract require attention to just distribution of societal resources. Both are important. If and when these responsibilities conflict how can they be reconciled? This talk will describe the problem of dual agency, the challenges it poses to contemporary US medical practice, and common solutions to address the challenge. These challenges will be illustrated with empirical data from recent research with doctors, and will outline empirical, normative, and policy opportunities to clarify and define what kind of role physicians can and should play in addressing healthcare costs with integrity.Item Posttrial responsibilities to participants in neural device research(2023-10-10) Hendriks, SaskiaDeveloping new therapeutic devices may reduce the high burden of neurological and psychiatric disorders. In trials in which participants benefit from the device, or explantation is risky, device-related care for participants after the trial ends is a major ethical and practical challenge. Most patients who benefit from a device want to keep it. However, they may need among others, follow-up visits, replacement hardware, and software updates to maintain their benefits and reduce risks. Most posttrial needs are currently inconsistently met, which can lead to major consequences for patients. In some cases, patients have been left with a defunct implant. While some guidance exists for pharmaceuticals, specific guidance or best practices for device trials are lacking. Do researchers, funders, and industry-partners have responsibilities to facilitate posttrial care for research participants?Item A test without risk and variable benefit: the story of the unsustainable growth of echocardiography(2014-04-11) Matulevicius, SusanItem [UT News](1986-07-30) Rutherford, Susan